Litigation

Recent Posts

Norton Rose Fulbright: Rise Of Predictive Coding For Pharmaceutical Companies
Posted on 2 Jan 2014 by Norton Rose Fulbright

By Jessica Sykora | Pharmaceutical and medical device companies in the midst of costly e-discovery battles and high-dollar litigation have more than likely heard the buzzwords "predictive coding" and "computer-assisted review" at... Read More

Supreme Court Questions Limits On Use Of Prescription Data
Posted on 27 Apr 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) The Supreme Court cast doubt Tuesday on efforts by states to limit drug manufacturers' use of information about the prescription drugs that doctors like to prescribe. The court took up a dispute between the state of Vermont... Read More

Ballard Spahr LLP: Pharmaceutical Companies Get Off-Label Marketing Victory
Posted on 18 Aug 2015 by Ballard Spahr LLP

. . . A federal judge ruled that the Food and Drug Administration (FDA) cannot prohibit a pharmaceutical company from marketing its drugs for off-label uses if its claims are truthful and not misleading. This ruling, while not precedential, alters the... Read More

Split U.S. Supreme Court Says Pharmaceutical Sales Reps Are Not Owed Overtime
Posted on 19 Jun 2012 by Bajeerah LaCava

WASHINGTON, D.C. - (Mealey's) A pharmaceutical sales representative, or detailer, falls under the U.S. Department of Labor's (DOL) definition of an "outside salesman" and is not owed overtime compensation, a split U.S. Supreme Court... Read More